Pursuant to Regulation 30 and other applicable provisions read with Schedule III of the SEBI LODR Regulations, 2015 ('SEBI Listing Regulations'), as amended from time to time, we wish to ....
Awaiting price reaction for this filing.
The board approved changing the company's name from Bijoy Hans Limited to Arvaya Healthcare Limited, suggesting a strategic pivot toward the healthcare sector. It also approved raising the borrowing limit to Rs. 200 crore and authorised loans, guarantees and investments up to Rs. 200 crore, along with up to Rs. 100 crore in related-party loans, all subject to shareholder approval. The authorised share capital will be increased more than three-fold, from Rs. 60 crore to Rs. 200 crore, and a postal ballot process was initiated to seek member approval. Key management changes include a revised pay package for Managing Director Kaushal Shah, revised pay for CFO Abhiram Ranganath from 1 April 2026, and Salil Shetty's shift from Non-Executive Director to Executive Director and CEO. Additionally, the board noted a non-binding Letter of Intent worth up to Rs. 5 crore to GTT Data Solutions for developing a technology platform.
Shareholders should brace for a significant rebranding into healthcare and a major expansion of the company's debt and capital envelope, which could dilute existing holders once the share capital increase is approved. The leadership reshuffle and large fund-raising plans signal an aggressive growth strategy but also bring execution and dilution risk.